Profile for China Patent: 116942629
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for China Patent: 116942629
| US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
|---|---|---|---|---|
| ⤷ Start Trial | Dec 11, 2034 | Helsinn Hlthcare | TRUSELTIQ | infigratinib phosphate |
| ⤷ Start Trial | Dec 11, 2034 | Helsinn Hlthcare | TRUSELTIQ | infigratinib phosphate |
| >US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |
